期刊文献+

C端截短的乙型肝炎病毒核心抗原的原核表达及免疫原性

Prokaryotic expression and immunogenicity of C-terminal truncated hepatitis B virus core antigen
原文传递
导出
摘要 目的 原核表达C端截短的乙型肝炎病毒核心抗原(hepatitis B virus core antigen,HBcAg)[HBcAg(aa 1-149)],并研究其在小鼠中的免疫原性.方法 用聚合酶链反应扩增C端截去34个氨基酸的HBcAg基因片段,构建含HBcAg(aa 1-149)基因的克隆质粒及表达质粒,在大肠杆菌Rossatta2中以异丙基-β-D-硫代半乳糖苷诱导重组蛋白的表达.表达产物经Ni2+亲和层析柱纯化后进行十二烷基硫酸钠-聚丙烯酰胺凝胶电泳(SDS-PAGE)、蛋白质印迹法鉴定.将纯化的重组蛋白免疫BALB/c小鼠,用ELISA法检测血清抗-HBc水平.结果 重组原核表达质粒pET15bHBcAg(aa 1-149)经双酶切和SDS-PAGE鉴定证明构建正确.重组HBcAg(aa 1-149)在大肠杆菌中获得高效表达,表达形式主要为可溶性蛋白.蛋白质印迹法显示在预期位置(相对分子质量约17 000位置)出现特异性条带.纯化后的重组蛋白纯度较高(>90%),并可在小鼠中诱生较高水平的抗-HBc.结论 重组HBcAg(aa 1-149)在原核系统中获得成功表达,并可在小鼠中诱导抗体应答. Objective To express the C-terminal truncated HBcAg(aa 1-149) in E.coli using genetic engineering methods,and study the immunogenicity of truncated HBcAg in BALB/c mice.Methods The C-terminal 34 aa truncated HBcAg gene fragment was amplified by PCR,and the cloning and expression plasmids containing HBcAg(aa 1-149) gene were constructed.The recombinant plasmid was transformed into E.coli Rossatta2 host cell The HBcAg(aa 1-149) fusion protein was expressed under the induction of IPTG,and identified by SDS-PAGE and Western blotting after Ni2+ affinity chromatography purification.BALB/c mice were immunized with HBcAg(aa 1-149),and the levels of antibody in serum was detected by ELISA.Results The restriction and SDS-PAGE analyses proved that recombinant plasmid pET15bHBcAg (aa 1-149) was constructed correctly.HBcAg (aa 1-149) was expressed in E.coli.The specific band of recombinant protein was showed at expected position (Mr 17 000 position) by Western blotting.The purity of purified HBcAg(aa 1-149) was more than 90%,and high levels of anti-HBc were induced in mice.Conclusion C-terminal truncated HBcAg is successfully expressed in prokaryotic cells and can induce humoral immune response in mice.
作者 张鹏艳 叶琳
出处 《国际生物制品学杂志》 CAS 2015年第1期1-5,共5页 International Journal of Biologicals
关键词 肝炎核心抗原 乙型 原核细胞 基因表达 蛋白纯化 免疫原性 Hepatitis B core antigen Prokaryotic cells Gene expression Protein purification Immunogenicity
  • 相关文献

参考文献13

  • 1骆抗先.乙型肝炎基础与临床[M].3版.北京:人民卫生出版社,2006.
  • 2Shimada N, Yamamoto K, Kuroda MJ, et al. HBcAg-specific CD8 T cells play an important role in virus suppression, and acute flare-up is associated with the expansion of activated memory T cells [J]. J Clin Immunol, 2003, 23(3):223-232.
  • 3Livingston BD, Crimi C, Fikes J, et al. Immunization with the HBV core 18-27 epitope elicits CTL responses in humans expressing different HLA-A2 supertype molecules [J]. Hum Immunol, 1999, 60(11): 1013-1017.
  • 4Heathcote J, McHutchison J, Lee S, et al. A pilot study of the CY-1899 T-cell vaccine in subjects chronically infected with hepatitis B virus. The CY1899 T Cell Vaccine Study Group [J]. Hepatology, 1999, 30(2): 531-536.
  • 5Pumpens P, Grens E. HBV core particles as a carrier for B cell/T cell epitopes [J]. Intervirology, 2001, 44(2/3): 98- 114.
  • 6张鹏艳,叶琳.乙型肝炎病毒核心抗原在大肠杆菌中的构建及表达[J].检验医学与临床,2010,7(17):1802-1803. 被引量:2
  • 7Huang Z, Santi L, LePore K, et al. Rapid,high-level produc- tion of hepatitis B core antigen in plant leaf and its immuno- genicity in mice [J]. Vaccine, 2006, 24(14): 2506-2513.
  • 8Sominskaya I, Skrastina D, Dislers A, et al. Construction and immunological evaluation of multivalent hepatitis B virus (HBV) core virus-like particles carrying HBV and HCV epitopes [J]. Clin Vaccine Immunol, 2010, 17(6): 1027- 1033.
  • 9Zlotnick A, Cheng N, Conway JF, et al. Dimorphism of hepa- titis B virus capsids is strongly influenced by the C-terminus of the capsid protein [J]. Biochemistry, 1996, 35 (23): 7412-7421.
  • 10Lobaina Y, Garcia D, Abreu N, et al. Mucosal immuno- genicity of the hepatitis B core antigen [J]. Biochem Biophys Res Commun, 2003, 300(3): 745-750.

二级参考文献43

  • 1吴琳,刁振宇,邓小昭,高健,周宗安,刘玉,王元伦.以HBc颗粒为呈现载体的猪囊虫疫苗的构建及其免疫学研究[J].中国人兽共患病杂志,2005,21(2):138-142. 被引量:2
  • 2Ferrari C,Penna A, Bertoletti A, et al. Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection[J]. J Immunol, 1990,145 (10) : 3443-3449.
  • 3Livingston BD, Crimi C, Fikes J, et al. Immunization with the HBV core 18-27 epitope elicits CTL responses in humans expressing different HLA-A2 supertype molecules [J]. Hum Immunol,1999,60(11) :1013-1017.
  • 4Heathcote J,Lee S. A pilot study of the CY-1899 T-cell vaccine in subjects chronically infected with hepatitis B virus[J].. Hepatology, 1999,30 (2) : 531-536.
  • 5Vanlandschoot P, Cao T, Leroux-roels G,et al. The nucleocapsid of the hepatitis B virus:a remarkable immunogenic structure[J].Antiviral Res, 2003,60 (2) :67-74.
  • 6骆抗先,朱幼芙,杨洁,侯金林,章廉,梁炽森.乙型肝炎病毒感染时的C基因热点变异[J].中华实验和临床病毒学杂志,1997,11(1):29-32. 被引量:12
  • 7Michel M L, Tiollais P. Hepatitis B vaccines: protective efficacy and therapeutic potential[J]. Pathol Biol (Par- is), 2010, 58(4): 288-295.
  • 8Antonio Roldao, Maria Candida M Mellado, Leda R Ca- stilho, et al. Virus-like particles in vaccine development [J]. Expert Rev Vaccines, 2010, 9(10): 1149-1176.
  • 9Ionescu R M, Przysiecki C T, Liang X, et al. Pharma- ceutical and immunological evaluation of human papillo- mavirus viruslike particle as an antigen carrier[J]. J Pharm Sci, 2006, 95(1): 70-79.
  • 10Pillay S, Meyers A, Witliamson A L, et al. Optimiza- tion of chimeric HIV-1 virus-like particle production in a baculovirus-insect cell expression system[J]. Biotechnol Prog, 2009, 25(4): 1153-1160.

共引文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部